What this study is
The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.
What's being tested
- Follow-up Interview
Intervention · OTHER
Non Applicable
Study details
- Sponsor
- Genomic Prediction Inc.
- Conditions
- Infertility · Genetic Disease · IVF
- Enrolling
- 10,000 people
- Starts
- 2020-07-11
- Est. completion
- 2050-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients indicating willingness to participate in research during informed consent to perform PGT
You can't join if
- Patients who opted out of participating in research during informed consent to perform PGT
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openGenomic Prediction Clinical Laboratory
North Brunswick, New Jersey, United States
- Talia Metzgar, RN · Contact(973) 529-4223Talia@genomicprediction.com
- Bhavini Rana · Contact(973) 529-4223bhavini@genomicprediction.com
- Nathan Treff, PhD · Principal investigator
Recruiting
Study team
Sponsor
Genomic Prediction Inc.
Study ID Genomic Prediction Inc 609
Principal investigator
Nathan R Treff, PhD
Genomic Prediction
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.